Skip to content
Screener

LeMaitre Vascular LMAT Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$61.0MMiss by $1.1M
EPS$0.62Beat by $0.06
Revenue estimate$62.2M
EPS estimate$0.56

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$67.4M
EPS estimate$0.69

Financials

Q3 2025

Income statement

See full
Revenue$61.0M+11.4%
Gross profit$46.0M+23.6%
Operating income$20.3M+54.5%
Net income$17.4M+55.8%
EPS (diluted)$0.75+53.1%

Balance sheet

See full
Cash & equivalents$25.5M+21.4%
Total debt$17.2M-6.1%
Total equity$378.9M+14.5%
Total assets$598.1M+58.6%

Cash flow

See full
Operating cash flow$28.8M+102%
CapEx$2.3M+36.6%
Free cash flow$26.5M+111%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.98B-5.0%
Enterprise value$1.97B-5.3%
P/E37.1×-13.3×
P/S8.2×-1.6×

Profitability

See full
Gross margin71%+2.6pp
Operating margin25.7%+2.4pp
Net margin22.1%+2.7pp
FCF margin27.5%+11.8pp

Returns & leverage

See full
Return on equity15%+1.7pp
Debt / equity0×0.0×
Current ratio13.6×+5.8×

FAQ

When did LeMaitre Vascular report Q3 2025 earnings?
LeMaitre Vascular (LMAT) reported Q3 2025 earnings on November 6, 2025 after market close.
What were LeMaitre Vascular's Q3 2025 revenue and EPS?
LeMaitre Vascular reported revenue of $61.0M and eps of $0.62 for Q3 2025.
Did LeMaitre Vascular beat estimates in Q3 2025?
Revenue missed the consensus estimate of $62.2M by $1.1M. EPS beat the consensus estimate of $0.56 by $0.06.
How did LeMaitre Vascular's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.4% from $54.8M a year earlier and eps grew 26.5% from $0.49.
Where can I find LeMaitre Vascular's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-269454) and the 10-Q periodic report (0001193125-25-270981) directly on SEC EDGAR. The filing index links above go to sec.gov.